Company page

Knight Therapeutics, Inc.

Knight Therapeutics, Inc. is a public company listed on the Canadian market under the ticker GUD. The company has a market capitalization of approximately CAD 647.2 million. Knight Therapeutics focuses on developing and commercializing innovative pharmaceutical products.

profileGUD:TSXAI content: aiUpdated June 24, 2026/company/knight-therapeutics-inc/c-uuxwow5b
Knight Therapeutics, Inc. logo
Ticker
GUD:TSX
Asset type
Stock
Market cap
$647.2M
Sector
Health Technology
Industry
Pharmaceuticals: Major
Exchange
TSX
Currency
CAD